Day: November 13, 2023

Vaxxinity to Present at Upcoming November Medical and Investor Conferences

Written by Customer Service on November 13, 2023. Posted in Public Companies.

CAPE CANAVERAL, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced that its scientists and executives will present and participate in meetings at three upcoming medical and investor conferences in November. Vaccines Summit – 2023Date: Tuesday, November 14, 2023 Time: 12:20 – 12:40 p.m. (ET)Title: UB-612: A novel peptide/protein subunit COVID-19 vaccine booster stimulated broadly neutralizing and Fc-mediated effector antibodies in a head-to-head Phase 3 randomized clinical trial Jefferies London Healthcare Conference Date: Wednesday, November 15, 2023 Time: 4:30 – 4:55 p.m. (GMT)Format: Fireside chat Evercore ISI 6th Annual HealthCONx Conference Date: Wednesday, November 29, 2023Time: 10:25 – 10:45 a.m. (ET)Format: Fireside...

CORRECTION – Asure Announces Third Quarter 2023 Results

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

Reports Third Quarter Revenues of $29.3 Million, Up 34% from Prior Year AUSTIN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Asure Software, Inc (Nasdaq: ASUR) please note that in the Guidance for 2024, the revenue should be 125.0M – 129.0M, not 125.0M – 127.0M as previously stated. The corrected release follows: Asure Software, Inc. (“we”, “us”, “our”, “Asure” or the “Company”) (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, today reported results for the Company’s third quarter ended September 30, 2023. Third Quarter 2023 Financial HighlightsRevenue of $29.3 million, up 34% from prior-year third quarter Recurring revenue of $23.8 million, up 19% from prior-year third quarter Net loss of $2.2 million, a...

Better Choice Company, Inc. Announces Third Quarter 2023 Results

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

Third Quarter 2023 Revenue Grew 11% Year-Over-Year to $13.1 millionAdjusted EBITDA Growth of 95% Year-Over-YearEPS Growth of 77% Year-Over-Year TAMPA, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (“Better Choice” or the “Company”) (NYSE American: BTTR), a pet health and wellness company, today announced its results for the third quarter ended September 30, 2023 (“Q3 2023”). THIRD QUARTER 2023 FINANCIAL HIGHLIGHTSRevenue increased 24% from second quarter 2023, and 11% year-over-year (“YOY”) to $13.1 million Operating loss improved 59% YOY to $(2.6) million Operating margin improved 3,403 basis points YOY to (-20%) Net loss improved 75% YOY to $(1.6) million Earnings (loss) per share (“EPS”) improved 77% YOY to ($0.05) Adjusted EBITDA improved 95% YOY to $(0.1) million1 Adjusted EBITDA margin improved 2,311...

STRATTEC SECURITY CORPORATION Announces CEO Transition Plan

Written by Customer Service on November 13, 2023. Posted in Public Companies.

MILWAUKEE, Nov. 13, 2023 (GLOBE NEWSWIRE) — STRATTEC SECURITY CORPORATION (NASDAQ:STRT) (“STRATTEC” or the “Company”), today announced that Frank J. Krejci, President and Chief Executive Officer, will retire from employment with the Company effective December 31, 2023. He will also retire from the Company’s Board of Directors on December 31st. Mr. Krejci became a member of STRATTEC’s inaugural Board of Directors in 1995 and has been a valued Board member for over 28 years. He became an Officer of STRATTEC in 2010, serving as President, and has served as President and Chief Executive Officer since September 1, 2012. Rolando Guillot, Senior Vice President – Operations and Chief Operating Officer, has been named to serve as Interim Chief Executive Officer effective January 1, 2024 in addition to his current role. Mr. Guillot joined...

Spectral AI Announces 2023 Third Quarter Financial Results

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

Highlights Continuing Progress in Developing and Commercializing AI-Driven DeepView® System Wound Healing Assessment Technology Affirms Full Year Revenue Guidance for 2023 and 2024 DALLAS, Nov. 13, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the third quarter ended September 30, 2023 (“Q3 2023”). “This has been an extraordinary period for Spectral AI, highlighted by our September listing on Nasdaq, continued progress towards developing and commercializing our AI-Driven DeepView® System wound healing assessment platform for burn and diabetic foot ulcers (“DFU”), and the recent receipt of the largest contract in...

Immuron CEO Steven Lydeamore Investor Webinar Presentation

Written by Customer Service on November 13, 2023. Posted in Public Companies.

MELBOURNE, Australia, Nov. 13, 2023 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to invite shareholders to attend an investor webinar on The Watchlist, to be held on Tuesday, 14th November, 2023, 1:00pm AEDT/10:00am AWST. CEO Steven Lydeamore will provide an overview and update on the business and upcoming milestones. Following the presentation, attendees will have the opportunity to ask questions directly to Mr Lydeamore during a moderated Q & A session. This webinar can be viewed live via zoom & you register via the link below. Zoom: https://share.hsforms.com/1ccfJimCATYqzCkvIKIC7VAd16zr A recorded copy of the webinar and presentation will be available on the Company’s website following the event. Authorised for release...

OTTAWA BANCORP, INC. Announces Third Quarter 2023 Results

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

OTTAWA, Ill., Nov. 13, 2023 (GLOBE NEWSWIRE) — Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding company for OSB Community Bank (the “Bank”), announced net income of $0.5 million, or $0.20 per basic and diluted common share for the three months ended September 30, 2023, compared to net income of $0.3 million, or $0.13 per basic and diluted common share for the three months ended September 30, 2022. For the nine months ended September 30, 2023, the Company announced net income of $1.5 million, or $0.58 per basic and diluted common share, compared to net income of $1.9 million, or $0.73 per basic and diluted common share for the nine months ended September 30, 2022. The loan portfolio, net of allowance, increased to $313.5 million as of September 30, 2023 from $307.7 million as of December 31, 2022 as originations of...

Navigator Holdings Ltd. Third Quarter 2023 Results (Unaudited)

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

LONDON, Nov. 13, 2023 (GLOBE NEWSWIRE) — HighlightsOn November 13, 2023, the Board declared a cash dividend of $0.05 per share of the common stock of Navigator Holdings Ltd. (the “Company”, “Navigator”, “we”, “our” and “us”) (NYSE: NVGS), for the quarter ended September 30, 2023 (the “Dividend”). The Dividend will be payable on December 21, 2023, to all shareholders of record as of the close of business New York time on December 7, 2023 which would have equated to a quarterly dividend payment of $3.7 million. As part of the Capital Return Policy for the quarter ended September 30, 2023, Navigator expects to repurchase approximately $1.1 million of the Company’s common stock (the “Share Repurchases”) between November 16, 2023 and December 31, 2023, subject to operating needs, market...

Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Written by Customer Service on November 13, 2023. Posted in Earnings Releases And Operating Results.

DALLAS, Nov. 13, 2023 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today reported its third quarter 2023 financial results and provided a corporate update. Recent Highlights and Anticipated Milestones:Presented novel preclinical data at SITC 2023 Annual Meeting demonstrating that its CoStimulatory Antigen Receptor (CoStAR) enhances activity of CD4+ T cells in multiple ways to broaden anti-tumor response and support CD8+ T cells Publication of ITIL-306 manuscript in Frontiers in Immunology (https://www.frontiersin.org/articles/10.3389/fimmu.2023.1256491/full), demonstrating that CoStAR enhances T cell activity and augments tumor reactivity of TILs in preclinical...

Avicanna Announces Appointment of Paul Fornazzari to Board of Directors

Written by Customer Service on November 13, 2023. Posted in Public Companies.

TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the commercialization of proprietary cannabinoid-based products and a medical cannabis care platform is pleased to announce the appointment of Paul Fornazzari to the board of directors. Paul Fornazzari is a business executive, securities lawyer, and board director with over twenty-five years of experience with growth-stage and established Canadian and international companies. Mr. Fornazzari is also a Partner focusing on Securities and Corporate Finance with Fasken Martineau DuMoulin (“Fasken”) one of Canada’s largest law firms with a well recognized domestic and international practice. In addition to English, Mr. Fornazzari is a fluent Spanish speaker from Latin America. “I...

Day: November 13, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice